• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Edoxaban Noninferior to Warfarin in Atrial Fibrillation After TAVI

    01 Sep 2021 //

    ESCARDIO

    Warfarin use significantly increases risk of knee and hip replacement

    10 Nov 2020 //

    EUREKALERT

    Portola`s Announces Results Andexxa was Associated with Lowest Rate of Mortality

    16 Mar 2020 //

    PR NEWSWIRE

    XARELTO Reduced the Risk of Strokes in Nonvalvular Atrial Fibrillation

    18 Mar 2019 //

    PR NEWSWIRE

    Cereno Scientific driving thrombosis prevention without bleeding-risks

    06 Dec 2018 //

    ENDPTS

    Increased use of anti-clotting drugs tied to fewer strokes in Afib

    25 Sep 2018 //

    REUTERS

    EMA advices Armetheon to conduct single 1000 patients study for tecarfarin

    16 Feb 2017 //

    PHARMABIZ

    INRatio Blood Monitoring Device Recalled Due to Inaccurate Readings

    24 Jan 2017 //

    NEWSINFERNO

    J&J clot fighter battles Pfizer/Bristol for warfarin

    26 Oct 2016 //

    FIERCE PHARMA

    Boehringer Launches Observational Study on Management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate mesylate)

    23 Mar 2016 //

    PR NEWSWIRE

    New blood thinner `antidote` to help doctors move past warfarin

    23 Dec 2015 //

    REUTERS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.